Physician profile
Patrick S Agnew
NPI 1265420756
$21,537.54
in general payments reported to CMS, 2019-2025
41 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,835 · 2020: $4,488 · 2021: $4,235 · 2022: $5,676 · 2023: $3,194 · 2024: $1,060 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,039 · Education: $1,800 · Travel and Lodging: $256 · Honoraria: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,039.41 |
| Education | $1,800.00 |
| Travel and Lodging | $256.12 |
| Honoraria | $208.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $15,414.00 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $1,963.34 | 2019-2025 | Citrefix, Variax, Ortholoc 3di |
| Smith+Nephew, INC. | $392.29 | 2019-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Depuy Synthes Sales INC. | $318.68 | 2019-2023 | Na |
| Convatec INC. | $285.02 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $228.40 | 2021-2025 | Nuzyra |
| Medtronic, INC. | $219.61 | 2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $208.00 | 2023 | Exparel |
| Organogenesis INC. | $202.33 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Allergan, INC. | $164.48 | 2019-2020 | |
| Globus Medical, INC. | $160.38 | 2025 | Senza |
| Misonix INC | $158.81 | 2019 | |
| Nevro Corp. | $149.07 | 2021-2023 | Senza |
| Horizon Therapeutics Plc | $146.64 | 2020-2022 | |
| Medartis INC. | $128.92 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.81 | 2021-2023 | Dalvance |
| Anika Therapeutics, INC. | $126.79 | 2023 | Toe Motion, Tactoset, Twist |
| Orthofix Medical, INC. | $124.69 | 2019 | |
| In2bones USA, LLC | $105.71 | 2020-2021 | |
| Melinta Therapeutics, LLC | $95.32 | 2019-2022 | |
| Bioventus LLC | $91.37 | 2019-2025 | Exogen Ultrasound Bone Healing System, Xcell, Exogen Ultrasound Bone Healing System |
| Acell, INC. | $67.81 | 2019-2020 | |
| Curonix LLC | $67.59 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paragon 28, INC. | $59.22 | 2019 | |
| Heron Therapeutics, INC. | $56.18 | 2021 | |
| Wright Medical Technology, INC. | $50.98 | 2019 | |
| Abbott Laboratories | $50.58 | 2023-2024 | Proclaim |
| Next Science LLC | $48.73 | 2023 | Surgx, Blastx, Xperience |
| Merck Sharp & Dohme LLC | $47.04 | 2019 | |
| Fidia Pharma USA INC. | $37.61 | 2019 | |
| Integra Lifesciences Corporation | $33.10 | 2020 | |
| Lifenet Health | $30.28 | 2023-2025 | Theragenesis Wound Matrix |
| Avita Medical Americas, LLC | $29.84 | 2023 | Recell |
| Averitas Pharma INC. | $25.13 | 2024 | Qutenza |
| Hikma Pharmaceuticals USA | $19.55 | 2019 | |
| Arthrosurface Incorporated | $19.36 | 2025 | Toe Motiontm |
| Sanara Medtech INC. | $19.14 | 2022 | |
| Reprise Biomedical, INC. | $16.68 | 2025 | Miro3d |
| Medela LLC | $15.99 | 2020 | |
| Tactile Systems Technology INC | $15.57 | 2020 | |
| Dynasplint Systems INC. | $14.50 | 2025 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Agnew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.